KRO vs MTUS

KRO exhibits severe financial weakness, anchored by a Piotroski F-Score of 2/9, indicating poor operational health and deteriorating fundamentals. The company transitioned from a profit in 2024 to a net loss of $110.9 million in 2025, driven by the cyclical downturn in the TiO2 market and unabsorbed fixed costs. Despite a low Price-to-Sales ratio and a strong current ratio, the company is plagued by negative profit margins and a consistent track record of missing earnings estimates (0/4 beats in the last year). With the current price of $7.21 trading significantly above the analyst target of $5.50, the risk-reward profile is unfavorable.

MTUS exhibits a severe divergence between its strong 1-year price performance (+48.1%) and its deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the company maintains a very clean balance sheet with minimal debt (Debt/Equity 0.02), it is struggling with negative operating margins and a catastrophic YoY EPS decline of 125%. The combination of consistent earnings misses and aggressive insider selling by the CEO and President suggests a lack of confidence in near-term operational recovery. Despite low valuation multiples (P/S 0.68), the lack of profitability makes the current price unsustainable without a significant turnaround in margins.